Oral versus Intravenous Antibiotics for Bone and Joint Infection
Questo studio è stato identificato come potenzialmente ad alto impatto.
La metrica High Impact di OE, guidata dall'AI, stima l'influenza che un articolo potrebbe avere integrando i segnali della rivista in cui è stato pubblicato e il contenuto scientifico dell'articolo stesso.
Sviluppato utilizzando un'elaborazione del linguaggio naturale all'avanguardia, il modello High Impact di OE prevede in modo più accurato la futura performance citazionale di uno studio rispetto al solo fattore di impatto della rivista.
Ciò consente di riconoscere prima le ricerche clinicamente significative e aiuta i lettori a concentrarsi sugli articoli che hanno maggiori probabilità di influenzare la pratica futura.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2022;10(1):10 N Engl J Med. 2019 Jan 31;380(5): 425-436.Cosa significa questo per la mia pratica?
The results of this study suggest that oral antibiotics are non-inferior to intravenous antibiotics for the management of bone and joint infection, as measured by treatment failure. Moreover, oral antibiotics are associated with a shorter length of stay and fewer complications compared to intravenous treatment. This study was limited by the open label design and potential differences in follow-on treatment. This study challenges the widely accepted standard use of intravenous antibiotics for bone/joint infection.
Riassunto dello studio
1054 patients being treated for bone or joint infection at 26 UK centers were randomized in this non-inferiority trial to receive 6 weeks of oral antibiotic therapy (n=527) or 6 weeks of intravenous antibiotic therapy (n=527). The primary outcome of interest was the rate of definite treatment failure. Secondary outcomes of interest included the rate of treatment discontinuation, catheter complications, diarrhea caused by C.difficile, serious adverse events, length of hospitalization, and patient-reported outcomes (Oxford Hip and Knee Scores [OHS; OKS]; EuroQual-5Dimension scores [EQ-5D]). Outcomes were assessed at 6 weeks, 4 months, and 1 year follow-up. Oral antibiotics were found to be non-inferior to intravenous antibiotics with regards to the risk of definitive treatment failure. The incidence of early discontinuation of treatment and catheter complications, and length of hospitalization were significantly higher in the intravenous group, however, no differences in the incidence of diarrhea or serious adverse events were observed between the two groups. EQ-5D scores and OHS scores were not significantly different between groups at 4 months and 1 year post-treatment, however, OKS scores were better in the oral group at both time points.
Perché questo studio era necessario ora?
Patients with bone and joint infection require prolonged antibiotic treatment, which is frequently delivered intravenously. However, the use of intravenous antibiotics has been associated with additional complications and higher costs vs. oral antibiotics. Therefore, it is of interest to determine whether oral antibiotics can provide an non-inferior management of bone and joint infection.
Qual era la domanda di ricerca principale?
In patients with acute or chronic bone/joint infection, is oral antibiotic therapy non-inferior to intravenous antibiotic therapy with respect to treatment success, within 1 year post-randomization?
DISCLAIMER
Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.
0 di 4 articoli mensili GRATUITI sbloccati
